Physician

Matthew C Hanggi, MD

According to 2025 Medicare claims, Matthew Hanggi, MD (NPI: 1043278336) practices micrographic dermatologic surgery in the Knoxville, TN market, with the plurality of this provider's patient population coming from Knox, TN. This provider's primary affiliated billing organization is KNOXVILLE DERMATOLOGY GROUP PC (NPI: 1760419014; TIN: 62-0964564) and primary practice location at 37922-3369.

Hanggi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,107 traditional Medicare patients, billed 5,737 HCPCS/CPT codes, and received $495,208 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 1,143 prescription claims across 606 beneficiaries totaling $511,728 in drug costs, led by Enbrel (Etanercept). Open Payments data shows 129 records totaling $2,227. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $282,011 and ending at $511,728. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,104	6,510	$587,962
2016	1,177	6,931	$636,046
2017	1,186	6,849	$647,324
2018	1,284	7,039	$662,846
2019	1,683	8,828	$669,381
2020	1,164	7,869	$560,494
2021	1,117	7,499	$562,403
2022	1,070	7,096	$546,374
2023	1,080	6,304	$524,415
2024	1,107	5,737	$495,208

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	371	670	$282,011
2016	408	759	$541,774
2017	387	639	$393,877
2018	320	561	$217,299
2019	443	836	$212,348
2020	492	985	$481,654
2021	536	1,062	$611,831
2022	563	1,164	$404,861
2023	550	1,141	$607,689
2024	606	1,143	$511,728

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17311	Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks	340	403	$446
17110	Destruction of skin growth, 1-14 growths	267	316	$72
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	667	938	$55
17000	Destruction of precancer skin growth, 1 growth	445	619	$32
17003	Destruction of precancer skin growth, 2-14 growths	331	1,925	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Enbrel	Etanercept	13	366	$200,509
Humira Pen	Adalimumab	12	392	$94,739
Dupixent Pen	Dupilumab	13	364	$50,583
Fluorouracil	Fluorouracil	53	1,314	$3,179
Triamcinolone Acetonide	Triamcinolone Acetonide	209	6,852	$2,874

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	129	$2,227	E.R. Squibb & Sons, L.L.C.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Matthew C. Hanggi, MD?

Tedicare shows public-source Medicare data for Matthew C. Hanggi, MD (NPI 1043278336), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Matthew C. Hanggi, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Matthew C. Hanggi, MD?

Matthew C. Hanggi, MD is linked to KNOXVILLE DERMATOLOGY GROUP PC (billing NPI 1760419014) in the available physician profile data.

Does Matthew C. Hanggi, MD have Open Payments data?

Matthew C. Hanggi, MD has 129 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.